Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label, Single-arm, Extension Study to Assess Long-term Safety of Evolocumab Therapy in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries

NCT03080935 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT03080935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03080935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label, Single-arm, Extension Study to Assess Long-term Safety of Evolocumab Therapy in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Terminated
Start date
March 13, 2017
Completion date
March 4, 2022
Enrollment
1,600 (actual)
Sites
85

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia